- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Velcade
Total 633 results
-
CephalonCompletedMultiple MyelomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedMelanoma | Solid Tumor | Brain and Central Nervous System TumorsUnited States
-
University of California, San FranciscoMillennium Pharmaceuticals, Inc.TerminatedB-cell Lymphoma | Non-Hodgkin's LymphomaUnited States
-
National Cancer Institute (NCI)CompletedB-Cell LymphomaUnited States
-
Emory UniversityMillennium Pharmaceuticals, Inc.Terminated
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCTerminated
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States
-
Michele CavoJanssen-Cilag S.p.A.Unknown
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLymphoma | Hodgkin LymphomaUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedAmyloidosisUnited States
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Breast Cancer | Ovarian Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCWithdrawnStudy of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
University of ArkansasTerminatedMultiple MyelomaUnited States
-
The Rogosin InstituteWeill Medical College of Cornell UniversityWithdrawn
-
University of California, San FranciscoTerminated
-
Accelerated Community Oncology Research NetworkMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Celgene CorporationCompletedMyelodysplasiaUnited States
-
ORA, Inc.Withdrawn
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterGenentech, Inc.; Millennium Pharmaceuticals, Inc.Withdrawn
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMultiple Myeloma | Non-Hodgkin's LymphomaIsrael, Italy, Poland, South Africa, United Kingdom
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Canada, Spain, Israel, United Kingdom, Germany, Austria, Belgium, France, Italy, Ireland, Netherlands, Sweden
-
Millennium Pharmaceuticals, Inc.Completed
-
Seoul National University HospitalRoche Pharma AGUnknownEnd Stage Renal DiseaseKorea, Republic of
-
Columbia UniversityUnknownMesotheliomaUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedA Study of Subcutaneous and Intravenous VELCADE in Patients With Previously Treated Multiple MyelomaMultiple MyelomaBelgium, France, Germany
-
Clinical Service, China307 Hospital of PLA; Chinese PLA General Hospital; Peking University Third Hospital and other collaboratorsUnknownMultiple Myeloma | Plasma Cell LeukemiaChina
-
PETHEMA FoundationCompleted
-
M.D. Anderson Cancer CenterCompletedMultiple MyelomaUnited States
-
University of ArkansasCompletedMULTIPLE MYELOMAUnited States
-
Peter MacCallum Cancer Centre, AustraliaCelgene Corporation; Janssen-Cilag Ltd.UnknownMultiple MyelomaAustralia
-
University of ArkansasTerminatedMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; Millennium...CompletedLymphoplasmacytic Lymphoma | Waldenstrom's MacroglobulinemiaUnited States
-
Ferring PharmaceuticalsCompleted
-
University of ArkansasWithdrawnMultiple MyelomaUnited States
-
Jules Bordet InstituteCompletedCarcinoma Breast Stage IVBelgium
-
Millennium Pharmaceuticals, Inc.TerminatedCarcinoma, Non-Small-Cell Lung | Adenocarcinoma, Bronchiolo-AlveolarUnited States
-
Gruppo Italiano Multiregionale per lo studio dei...University of Turin, Italy; Fondazione Italiana Linfomi ONLUS; Centro di Riferimento...CompletedLymphoma | Non-Hodgkin LymphomaItaly
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; Johnson & Johnson Pharmaceutical Research...Completed
-
SanofiCompletedMultiple MyelomaFrance, Italy
-
Lymphoma Study AssociationJanssen-Cilag International NVTerminatedFollicular LymphomaFrance, Belgium
-
University of KentuckyNational Institutes of Health (NIH)CompletedAcute Myelogenous LeukemiaUnited States
-
Massachusetts General HospitalMillennium Pharmaceuticals, Inc.Completed
-
University of ArkansasCompleted
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States